NASDAQ:CLRB

Cellectar Biosciences Stock Predictions

etoro logo Buy CLRB
*Your capital is at risk
$2.60
-0.140 (-5.11%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

CLRB Prediction Chart

CLRB Predictions History

Latest community submissions for CLRB.
Predictor Target Session Target Price Result Direction Accuracy Score
Jan 29, 2024 Bullish $4.21 V 1
Skagitqg Skagitqg Merchant
Jan 29, 2024 Bullish $4.21 V 1
jjsheets330 jjsheets330 Merchant @jjsheets330.186247
Mar 15, 2021 $4.50 -76.56% $1.92 X 0.00% 0
Jose M Verhelst Jose M Verhelst @JoseMVerhelst.193604
Mar 15, 2021 Bullish $1.92 X 0
JS JS Pro
Dec 22, 2020 $2.49 -91.01% $2.77 V 89.89% 0
JS JS Pro
Dec 18, 2020 $2.07 -90.88% $2.27 V 91.19% 0
JS JS Pro
Dec 14, 2020 $2.22 -89.28% $2.07 X 92.75% 0
JS JS Pro
Oct 9, 2020 $1.38 -89.38% $1.30 X 93.85% 0
JS JS Pro
Feb 14, 2020 $3.02 -89.69% $2.93 X 96.93% 1
Clint K Clint K @ClintK.139803
Feb 14, 2020 Bearish $2.93 V 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CLRB with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CELLECTAR BIOSCIENCES
Cellectar Biosciences
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients;...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE